RET and medullary thyroid gland carcinoma: Among them, high iodine intake is a high-risk factor for BRAF gene mutations in PTC patients; RET gene testing can be performed for MTC patients, and RET mutations are closely related to tumor invasiveness and poor prognosis (19).